CAS 55203-24-2 | Dexamethasone Sodium Phosphate
Product name:Dexamethasone sodium phosphate
CAS:55203-24-2
MF:C22H28FNa2O8P
MW:516.4
EINECS:219-243-0
MDL No.:MFCD00079105
Specification:
|
Appearance
|
White to slightly yellow crystalline powder, free from visible evidence of contamination, very hygroscopic.
|
| Identification |
A. the RF value of the principle spot obtained from the test solution corresponds to that obtained from the standard solution.
|
|
B. The residue from the ignition of it meets the
requirements of the test for Phosphate <191> and for
Sodium<191>.
|
|
|
Assay
|
97.0%~102.0% |
|
Limit of the phosphate ions
|
≤1.0% |
|
Water
|
≤16.0%
|
|
Residual solvents
|
Acetone ≤5000ppm
|
|
Methanol ≤5000ppm
|
|
|
Alchohol content
|
≤8.0% |
|
Chromtographic purity |
Any individual impurity ≤1.0% |
|
Total impurities ≤2.0% |
|
| Free Dexamethasone |
≤1.0%
|
| Specific rotation |
﹢74°~﹢82° |
|
pH
|
7.5~10.5
|
|
Microbial limit
|
Aerobic Bacteria ≤1000cfu/g
|
|
Mold and yeast≤100cfu/g
|
|
|
e.Coli can not be detected
|
|
|
Bacterial endotoxin
|
<1.2EU/mg
|
Application:
Dexamethasone sodium phosphate, also known as 16 α - methyl-11 β, 17 α, 21 trihydroxy-9 α - fluoropregnest-1,4-diene-3,20-dione-21-phosphate disodium salt, is an adrenal cortex hormone drug with anti-inflammatory, anti allergic, anti rheumatic, and immunosuppressive effects.
| Market Applications | |
| 1. Injectable Pharmaceuticals |
- Emergency & Critical Care: IV/IM for severe shock, sepsis, anaphylaxis, and acute respiratory distress- Neurology: IV for cerebral edema (tumor/trauma) and meningitis - Rheumatology & Autoimmunity: IV/IA for rheumatoid arthritis, lupus, and vasculitis - Respiratory: IV for severe asthma, COPD exacerbations, and pulmonary edema - Oncology: Adjunct for leukemia, lymphoma, and chemotherapy-induced nausea |
| 2. Ophthalmic Preparations | - Eye drops/ointments for conjunctivitis, keratitis, iritis, and post-surgical inflammation |
| 3. Veterinary Medicine | - Anti-inflammatory/anti-allergic for livestock/pets; shock, arthritis, and allergic reactions |
| 4. API & Formulation Intermediate | - Raw material for injectables, ophthalmics, and topical creams; key intermediate for dexamethasone derivatives |
Synonyms:
DEXAMETHASONE SODIUM PHOSPHATE
2392-39-4
Dexamethasone 21-phosphate disodium salt
55203-24-2
Dalalone
Dexadreson
Dexamethasone disodium phosphate
Decadron phosphate
Dexabene
Spersadox
Sodium dexamethasone phosphate
| Properties |
Safety Information |
|
Melting point:204-206°C (dec.) storage temp. 2-8°C solubility H2O: 50 mg/mL, clear, faintly yellow form Solid color white to off-white Stability:Hygroscopic |
Hazard Codes Xn |
Hot Tags: CAS 55203-24-2 | Dexamethasone Sodium Phosphate, China CAS 55203-24-2 | Dexamethasone Sodium Phosphate manufacturers, suppliers, Ribonuclease A, biochemical cell culture, Bakuchiol, biochemical regenerative medicine, N-Acetyl-D-mannosamine, Guanosine 5 triphosphoric aicd disodium salt


